Assad J. Kazeminy, Ph.D., is the Founder and former CEO of Irvine Pharmaceutical Services Inc. and Avrio Biopharmaceutical LLC. He founded those companies in 1988 and 2008. In October 2016 the companies were acquired by a Japanese firm.
Dr. Kazeminy received his Doctorate Degree. In the Pharmaceutical Sciences from Esfahan University, Esfahan, Iran and continued his graduate studies in Biochemistry at Colorado State University. He has done his Post Doctorate at the University of Southern California Medical School, Department of Pharmacology. In addition, Dr. Kazeminy has taught at USC and has conducted research at the University of California, Irvine.
Dr. Kazeminy has served as a member of Dean Advisory Panel at Chapman University School of Pharmacy since 2014. He has been appointed as Executive Industry Liaison and Adjunct Professor of Pharmacy at Chapman University School of Pharmacy. Dr. Kazeminy has served as a member of the United States Pharmacopeia (USP) Expert Committee since 2000.
He has served as a board member of UCI Applied Innovation. He served as a Board Member of the Physical Science Dean’s Leadership Council. He recently accepted an invitation to become board member of Dean’s Leadership Council at UCI School of Pharmaceutical Science. Dr. Kazeminy also serves on the Board of Directors of TheraVida, Inc. a drug development company, which he started in 2005.
Dr. Kazeminy has been awarded by United States Pharmacopeia a Winner For Innovative Responses to a Public Health Challenge related to his outstanding work on a new General Chapter of USP on elemental Impurity.